A recent study uncovered the underlying connection between early childhood antibiotic use and heightened asthma risk. Researchers identified that the elevated risk stems from the depletion of a gut-produced molecule known for its protective properties.
The research team from Monash University identified a molecule called IPA, produced by gut bacteria, that shows promise as a dietary supplement in the future to prevent asthma development in children at risk of the disease. The results of the study were published in the journal Immunity.
.jpg?w=600)
